Skip to main content
. 2019 Sep 2;17:73. doi: 10.1186/s12958-019-0520-9

Table 2.

Comparison of IVF outcomes in groups with different MediDiet adherence

Higher adherence (n = 228) Lower adherence (n = 362) P
COH protocol 0.258 b
 GnRH agonist long 173 (75.88%) 290 (80.11%)
 GnRH antagonist 55 (24.12%) 72 (19.89%)
Gn duration (day) 11.60 ± 2.25 11.57 ± 2.27 0.848 a
Dosage of Gn (IU) 2782.2 ± 1109.1 2840.9 ± 1160.2 0.597 a
LH of HCG day (IU/L) 2.05 ± 2.37 1.95 ± 2.15 0.392 a
E2 of HCG day (pg/ml) 3494.9 ± 1450.6 3303.0 ± 1396.3 0.052 a
P of HCG day (ng/ml) 1.72 ± 3.18 1.57 ± 2.46 0.425 a
No. of oocytes retrieved 13.98 ± 7.49 12.86 ± 6.51 0.070 a
No. of fertilized oocytes 10.88 ± 6.33 9.83 ± 5.52 0.067 a
Insemination method 0.754 b
 IVF 154 (67.54%) 240 (66.30%)
 ICSI 74 (32.46%) 122 (33.70%)
Fertilization rate (%) 78.40 ± 19.47 76.42 ± 20.51 0.261 a
No. of embryos available 8.40 ± 5.26 7.40 ± 4.71 0.028 a
Available embryo rate (%) 76.32 ± 20.33 75.36 ± 21.99 0.840 a
No. of top-quality embryos 2.01 ± 2.42 2.01 ± 2.47 0.967 a
No. of ET cycles 61 106
Endometrial thickness(mm) 12.69 ± 2.09 12.77 ± 2.69 0.836 a
No. of embryos transferred 1.93 ± 0.25 1.99 ± 0.17 0.086 a
Clinical pregnancy rate 42.62%(26) 50.94%(54) 0.300 b
Implantation rate 27.97% (33/118) 31.75% (67/211) 0.533 b

NOTE: Data are presented as mean ± standard deviation or n (%); No. number; COH controlled ovarian hyperstimulation, Gn gonadotropin; a Mann-Withney U test; b Chi-square test